Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride plus tamsulosin vs tamsulosin in benign prostatic hyperplasia
CTR20140283Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by GSK. Started Feb 2015; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on CTR20140283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140283.